Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

Thumbnail

Digital solution for heart failure gains FDA’s breakthrough device designation

The digital therapeutic helps patients follow recommended treatment guidelines by monitoring their health data, connecting them to healthcare providers and personalizing their treatment when necessary.

Thumbnail

Hearts from donors with a history of drug use are safe for transplant

"We thought that illicit drugs like cocaine or methamphetamine, which can lead to heart attacks, would prove to be dangerous,” one researcher said. "However, we were wrong."

Thumbnail

Quality intervention fails to boost outcomes for HFrEF patients

Researchers aimed to use a proven strategy to improve patient care, but their intervention did not make a substantial impact. 

Thumbnail

Increased physical activity after ICD implantation lowers the risk of death, hospitalization

Participation in cardiac rehabilitation programs remains low, the authors wrote, but this study showed that it can make a significant impact on patient outcomes. 

Thumbnail

Heart failure specialists raise $80M to ramp up work on new ventricular repair solution

The company also named the newest member of its board of directors.

healthcare value value-based care money dollar

Catheter ablation a cost-effective option for HF patients with AFib

Researchers shared their full analysis in the Journal of the American Heart Association.

Thumbnail

Cardiologists sound alarm on ongoing methamphetamine epidemic

Methamphetamine-related heart failure hospitalizations increased 585% from 2008 to 2018, researchers found. 

Empagliflozin boosts care for HFpEF patients, new clinical trial confirms

Researchers will provide a full breakdown of the study's findings in August.